Literature DB >> 8824295

Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway.

E Gulbins1, K M Coggeshall, B Brenner, K Schlottmann, O Linderkamp, F Lang.   

Abstract

Fas induces apoptosis in lymphocytes via a poorly defined intracellular signaling mechanism. We and others have previously demonstrated the involvement and significance of a signaling cascade from the Fas receptor via sphingomyelinases and ceramide to Ras in apoptosis (Gulbins, E., Bissonette, R., Mahboubi, A., Nishioka, W., Brunner, T., Baier G., Baier-Bitterlich, G., Byrd, C., Lang, F., Kolesnick, R., Altman, A., and Green, D. (1995) Immunity 2, 341; Cifone, M. G., DeMaria, R., Roncali, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., and Testi, R. (1994) J. Exp. Med. 180, 1547-1552; Gill, B. M., Nishikata, H., Chan, G., Delovitch, T. L., and Ochi, A. (1994) Immunol. Rev. 142, 113-126). Here, we demonstrate an activation of the small G-proteins Rac 1 and Rac 2 after Fas receptor triggering. Expression of a transdominant inhibitory Ras mutant (N17Ras) prevents Rac 1 and Rac 2 stimulation, suggesting a signaling cascade from the Fas receptor via Ras to Rac 1 and Rac 2. Genetic and pharmacological inhibition of Ras or Rac 1 and Rac 2 stimulation blocks Fas-induced apoptosis, pointing to an important function of a Ras and Rac protein-regulated signaling pathway in Fas-mediated programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824295     DOI: 10.1074/jbc.271.42.26389

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration.

Authors:  Raja Rajeswari Sivalenka; Rolf Jessberger
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  RhoG GTPase controls a pathway that independently activates Rac1 and Cdc42Hs.

Authors:  C Gauthier-Rouvière; E Vignal; M Mériane; P Roux; P Montcourier; P Fort
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

4.  L-selectin activates the Ras pathway via the tyrosine kinase p56lck.

Authors:  B Brenner; E Gulbins; K Schlottmann; U Koppenhoefer; G L Busch; B Walzog; M Steinhausen; K M Coggeshall; O Linderkamp; F Lang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes.

Authors:  T H Chuang; K M Hahn; J D Lee; D E Danley; G M Bokoch
Journal:  Mol Biol Cell       Date:  1997-09       Impact factor: 4.138

6.  Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production.

Authors:  N Embade; P F Valerón; S Aznar; E López-Collazo; J C Lacal
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

7.  Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

Authors:  D A Martin; L Zheng; R M Siegel; B Huang; G H Fisher; J Wang; C E Jackson; J M Puck; J Dale; S E Straus; M E Peter; P H Krammer; S Fesik; M J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 8.  Ceramide signaling in mammalian epidermis.

Authors:  Yoshikazu Uchida
Journal:  Biochim Biophys Acta       Date:  2013-09-19

9.  Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes.

Authors:  Renu A Kowluru; Anjan Kowluru; Mamta Kanwar
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

10.  Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.

Authors:  I Timokhina; H Kissel; G Stella; P Besmer
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.